Clinical Trial Update: Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy trial of levodopa-carbidopa intestinal gel in Parkinson's disease completed; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Duopa (levodopa-carbidopa intestinal gel) (levodopa-carbidopa intestinal gel)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Dyskinesias, Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2015-01-16